NUSAP1 and gastric cancer: The IHC results reveal that NUSAP1 was upregulated in GC tissues (90/161, 56%), and the staining of NUSAP1 increased markedly with clinical TNM stage (Figure 2D), indicating that overexpression of NUSAP1 contributes to GC tumorigenesis and progression.